FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+10.36%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$21.3B
AUM Growth
+$21.3B
(+19%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
9.16%
Top 10 Holdings %
Top 10 Hldgs %
45.78%
Holding
160
New
16
Increased
36
Reduced
30
Closed
18
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$3.4B |
| 2 |
Amazon
AMZN
|
$666M |
| 3 |
Aon
AON
|
$223M |
| 4 |
Thermo Fisher Scientific
TMO
|
$141M |
| 5 |
AZEK
The AZEK Co
AZEK
|
$109M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
$816M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$403M |
| 3 |
Exelixis
EXEL
|
$286M |
| 4 |
Microsoft
MSFT
|
$268M |
| 5 |
Intuit
INTU
|
$239M |
Sector Composition
| 1 | Healthcare | 34.23% |
| 2 | Technology | 14.54% |
| 3 | Financials | 10.03% |
| 4 | Communication Services | 6.05% |
| 5 | Industrials | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
151
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – | -3,055,000 | Closed | -$403M |
|
152
Biohaven
BHVN
$1.63B
| – | – | -4,813,167 | Closed | -$116M |
|
|
BPMC
153
DELISTED
Blueprint Medicines
BPMC
| – | – | -4,000 | Closed | -$354K |
|
154
BeyondSpring
BYSI
$69.4M
| – | – | -19,000 | Closed | -$58K |
|
155
Chemed
CHE
$6.67B
| – | – | -400 | Closed | -$246K |
|
|
DFS
156
DELISTED
Discover Financial Services
DFS
| – | – | -4,780,000 | Closed | -$816M |
|
157
Elanco Animal Health
ELAN
$9.12B
| – | – | -16,000 | Closed | -$168K |
|
158
Forte Biosciences
FBRX
$137M
| – | – | -70,429 | Closed | -$547K |
|
159
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| – | – | 0 | – | – |
|